Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruxolitinib cream in Lichen Sclerosus
NCT05593445Phase 2Completed
- Sponsor
- Incyte
- Start
- Nov 2022
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ruxolitinib cream in lichen sclerosus (LS), sponsored by Incyte. Started Nov 2022; status: completed.
02
Drugs
ruxolitinib cream
03
Conditions
lichen sclerosus (LS)
Beyond the preview
Go deeper on NCT05593445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05593445.